Conometric Abutment and Conometric Final Cap for Jaw, Edentulous, Partially

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Jaw, Edentulous, Partially+1 More
Conometric Abutment and Conometric Final Cap - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at a new way to seat crowns on teeth without using cement or screws, to see how well it works after a year.

Eligible Conditions
  • Jaw, Edentulous, Partially

Treatment Effectiveness

Study Objectives

0 Primary · 6 Secondary · Reporting Duration: 1, 3 and 5 years after permanent restoration

Year 5
Bleeding on Probing
Implant survival
Marginal Bone Levels alterations
Plaque
Probing Pocket Depth
Year 5
Prosthetic survival

Trial Safety

Trial Design

1 Treatment Group

Single tooth restorations using Acuris conometric concept
1 of 1
Experimental Treatment

157 Total Participants · 1 Treatment Group

Primary Treatment: Conometric Abutment and Conometric Final Cap · No Placebo Group · N/A

Single tooth restorations using Acuris conometric concept
Device
Experimental Group · 1 Intervention: Conometric Abutment and Conometric Final Cap · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1, 3 and 5 years after permanent restoration

Who is running the clinical trial?

Dentsply Sirona ImplantsLead Sponsor
62 Previous Clinical Trials
4,524 Total Patients Enrolled
13 Trials studying Jaw, Edentulous, Partially
1,054 Patients Enrolled for Jaw, Edentulous, Partially
Marco Degidi, Dr.Principal InvestigatorDegidi Dental Clinic, Bologna, Italy

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged between 18 and 75 years.
Presence of natural tooth, partial prosthesis and/or implant supported restoration in the opposite jaw in contact with the planned crown.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: October 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Kentucky25.0%
Ohio25.0%
Alabama25.0%
Other25.0%
How old are they?
18 - 65100.0%
What site did they apply to?
University of Illinois College of Dentistry100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Typically responds via
Email100.0%